drug · antibody
patient view →ianalumab
Phase 3updated 2mo agoby $NVS NOVARTIS AG🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 15 investigational indications.
targets
Tumor necrosis factor receptor superfamily member 13C
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that